manufacturing - Bioprocess Development Forum

Articles Regulatory Upstream

September 6, 2024

Considering Process Scaling for Monoclonal Antibodies During Early Phase Development

Successful biomanufacturing processes not only provide the desired product in high yield and purity, they…

Ross Burns

Articles Downstream

September 5, 2024

Automation Downstream Controls Quality

Automation in bio/pharmaceutical manufacturing offers a reduction in human intervention, which can enhance quality in…

Ross Burns

Articles Upstream

August 8, 2024

Under pressure: exploring root causes of leaks in single-use mixers

Single-use technology offers huge benefits for both flexibility and efficiency. It reduces downtime by eliminating

Ross Burns

Articles BioPharma Upstream

August 5, 2024

Sterilization Trends for Single-Use Consumables

Single-use (SU) technologies increasingly find use today at all phases of the drug development cycle…

Ross Burns

Articles BioPharma

July 13, 2023

Pulling Out All the Stops in mAb Manufacturing

While the biopharma industry is pushing the barriers with antibody development, it must also contend…

admin-element

Articles Downstream

June 13, 2023

Pushing the Barriers in Next-Gen Antibody Development

Continued development of new and next-generation antibodies is spurred by the increasing demand for more…

admin-element

Articles

March 24, 2023

Manufacturing mRNA for research and beyond

This eBook guides you in the practical aspects of setting up an mRNA research laboratory.

admin-element

Articles

October 21, 2021

mRNA Vaccines: Current Trends and Perspectives

mRNA therapy is a rapidly growing field. The technology offers great benefit and potential for...

admin-element

Articles Downstream Regulatory Upstream

March 25, 2021

Basics in Process Development for Biotherapeutics

Definitions, activities, and things to consider when developing an upstream or downstream bioprocess.

admin-element

Articles BioPharma Downstream Regulatory Upstream

January 14, 2021

Updating Viral Clearance for New Biologic Modalities

Viral clearance processes and guidance must evolve along with newer biotherapeutic modalities.

admin-element